The Fox Chase Chemical Diversity Center Announces it Has Been Awarded a Phase II SBIR from the National Institute of Aging (NIA) Entitled “PET Imaging Agents for the in vivo Detection of TDP-43”
Doylestown, PA. September 12, 2017- FCCDC is pleased to announce that it has been awarded a Phase II SBIR from the National Institute of Aging (NIA) entitled “PET Imaging Agents for the in vivo Detection of TDP-43” (1R44AG059278-01, Principal Investigator: Allen Reitz).